Alza (Pharmaceuticals and Biotechnology) Overview
Latest Deal Amount
$12.3B
Alza (Pharmaceuticals and Biotechnology) General Information
Description
Manufacturer of drug delivery systems created to develop pharmaceutical products with enhanced therapeutic value. The company's drug delivery systems include therapeutic devices for oral, transdermal, implantable and liposomal technologies, enabling healthcare sector to innovate and create novel medicines for the cure of chronic and life-threatening diseases.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Alza (Pharmaceuticals and Biotechnology) Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 4. Merger/Acquisition |
22-Jun-2001 |
$12.3B |
|
000.00 |
Completed |
Profitable |
| 3. Merger/Acquisition |
17-Dec-1999 |
00.00 |
|
00.00 |
Cancelled |
Profitable |
| 2. IPO |
08-Jun-1983 |
|
|
|
Completed |
Generating Revenue |
| 1. Early Stage VC |
|
|
|
|
Completed |
Startup |